| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00109-009-0544-2 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s00109-009-0544-2 |
| P932 | PMC publication ID | 2772954 |
| P698 | PubMed publication ID | 19834654 |
| P5875 | ResearchGate publication ID | 38015895 |
| P2093 | author name string | Harald H H W Schmidt | |
| Mylinh La | |||
| Kirstin Wingler | |||
| Melanie E Armitage | |||
| P2860 | cites work | NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential | Q24656131 |
| The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology | Q27860991 | ||
| Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 | ||
| Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling | Q28583271 | ||
| NO-independent regulatory site on soluble guanylate cyclase | Q32165040 | ||
| Novel aspects of oxidative stress in cardiovascular diseases. | Q33815017 | ||
| Enzymes of arginine metabolism | Q34355739 | ||
| Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent | Q34501431 | ||
| The 'A's and 'O's of NADPH oxidase regulation: a commentary on "Subcellular localization and function of alternatively spliced Noxo1 isoforms". | Q34594833 | ||
| Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension | Q34957241 | ||
| Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels | Q35009484 | ||
| NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle | Q35044464 | ||
| Nitric oxide synthase inhibition as therapy for sepsis: a decade of promise | Q35069190 | ||
| Nitric oxide in myocardial ischemia/reperfusion injury | Q35666882 | ||
| Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy | Q36052377 | ||
| Molecular composition and regulation of the Nox family NAD(P)H oxidases | Q36255498 | ||
| Selective inhibitors of inducible nitric oxide synthase: potential agents for the treatment of inflammatory diseases? | Q36384977 | ||
| Nitric oxide and the vascular endothelium. | Q36603016 | ||
| Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury | Q36732994 | ||
| NADPH oxidase inhibitors: new antihypertensive agents? | Q36897941 | ||
| New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance | Q36972443 | ||
| Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease | Q36995833 | ||
| L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous? | Q37036435 | ||
| Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects | Q37087728 | ||
| Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension | Q37102515 | ||
| NOX enzymes as novel targets for drug development | Q37176104 | ||
| Differential vascular functions of Nox family NADPH oxidases | Q37260191 | ||
| NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. | Q37274118 | ||
| Selective targeting of NADPH oxidase for cardiovascular protection | Q37313563 | ||
| Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery | Q39643032 | ||
| Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation | Q39845753 | ||
| Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. | Q40034272 | ||
| Heat shock protein 90 regulates stabilization rather than activation of soluble guanylate cyclase | Q42030989 | ||
| YC-1, a novel activator of platelet guanylate cyclase | Q42275468 | ||
| Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. | Q42474778 | ||
| Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase | Q43952389 | ||
| Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation | Q44365406 | ||
| Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure. | Q46006828 | ||
| Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes | Q46390291 | ||
| Coronary artery superoxide production and nox isoform expression in human coronary artery disease | Q46809296 | ||
| Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. | Q53631843 | ||
| Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells | Q63365807 | ||
| Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor | Q70139376 | ||
| Spectral and ligand-binding properties of an unusual hemoprotein, the ferric form of soluble guanylate cyclase | Q71010153 | ||
| Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells | Q83125724 | ||
| Decision analysis supports the paradigm that indiscriminate supplementation of vitamin E does more harm than good | Q83476489 | ||
| P433 | issue | 11 | |
| P921 | main subject | nitric oxide synthase | Q417619 |
| nitrogen oxide | Q424418 | ||
| oxidative stress | Q898814 | ||
| NADPH oxidases | Q97651124 | ||
| P304 | page(s) | 1071-1076 | |
| P577 | publication date | 2009-10-16 | |
| 2009-11-01 | |||
| P1433 | published in | Journal of Molecular Medicine | Q6295593 |
| P1476 | title | Translating the oxidative stress hypothesis into the clinic: NOX versus NOS. | |
| P478 | volume | 87 |
| Q89771592 | An Effective NADPH Oxidase 2 Inhibitor Provides Neuroprotection and Improves Functional Outcomes in Animal Model of Traumatic Brain Injury |
| Q36424922 | Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice |
| Q30315850 | Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats |
| Q46359673 | Chronic administration of sodium nitrite prevents hypertension and protects arterial endothelial function by reducing oxidative stress in angiotensin II-infused mice |
| Q90227707 | Combined Treatment with Three Natural Antioxidants Enhances Neuroprotection in a SH-SY5Y 3D Culture Model |
| Q89848914 | Minireview on the Relations between Gut Microflora and Parkinson's Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities |
| Q42615181 | Monash at the academic industrial interface: trains and platforms. |
| Q37589114 | NADPH oxidase in brain injury and neurodegenerative disorders |
| Q38054458 | NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury |
| Q52344406 | NADPH oxidases in traumatic brain injury - Promising therapeutic targets? |
| Q96609757 | Non-canonical chemical feedback self-limits nitric oxide-cyclic GMP signaling in health and disease |
| Q82623891 | Oxidative stress and enhanced sympathetic vasoconstriction in contracting muscles of nitrate-tolerant rats and humans |
| Q88800229 | Prior intake of Brazil nuts attenuates renal injury induced by ischemia and reperfusion |
| Q42609911 | Rational design of small molecule inhibitors targeting the Rac GTPase-p67(phox) signaling axis in inflammation. |
| Q85312868 | Sodium nitrite causes relaxation of the isolated rat aorta: By stimulating both endothelial NO synthase and activating soluble guanylyl cyclase in vascular smooth muscle |
| Q35122712 | The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats |
| Q57269732 | The aporphine alkaloid boldine improves endothelial function in spontaneously hypertensive rats |
| Q34403921 | Updates of reactive oxygen species in melanoma etiology and progression |
Search more.